Navigation Links
Government at all Levels Will Continue to Spend on Essential Services and Invest in the Future, According to Onvia Study
Date:1/8/2009

45 Percent of Government Officials Expect to Maintain or Increase Spending Activity in 2009, With the Focus on Construction of Roads and Bridges, Creation of 21st Century Schools and Modernization of Energy-Inefficient Government Facilities

SEATTLE, Jan. 8 /PRNewswire-FirstCall/ -- President-Elect Barack Obama's economic stimulus package outlines a significant increase in federal spending on "shovel-ready" construction of roads and bridges, 21st-century school projects, healthcare IT and modernization of energy-inefficient government facilities. In response, states and municipalities are prioritizing their initiatives based on the greatest short-term impact to their respective regions. This is according to a new report released today by Onvia (Nasdaq: ONVI), the leading provider of business-to-government solutions in the United States, covering the broadest set of industries and products at every level of government.

Onvia's 2009 Government Market Outlook, available at www.Onvia.com/2009outlook, summarizes findings of a recent survey of more than 4,000 government executives, managers and purchasing officials at state, local and educational purchasing offices, and reflects anticipated opportunities from the economic stimulus package. The survey looked at projected spending activities in government agencies throughout the country and across the categories of infrastructure, technology and business services.

Highlights from Onvia's 2009 Government Market Outlook include the following:

Overall Government Spending

  • 20 percent of officials surveyed project an increase in government spending activity across 2009.
  • 25 percent surveyed
    '/>"/>

SOURCE Onvia
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death
2. Government Launches Nursing Home Rating System
3. Holland & Knight Welcomes MARC Associates - Experts in Health Care and Intergovernmental Policy - to the Firms Public Policy & Regulation Practice
4. According to a New Government Survey, 38 Percent of Adults and 12 Percent of Children Use Complementary and Alternative Medicine
5. In New Jersey, a Blue-Ribbon State Government Commission Tells Governor Corzine and the Legislature: Its Time to Enact Marriage Equality
6. Noted State Government Medical Director Dr. Stephen Saunders To Join APS Healthcare
7. Exceeding the Government's Minimum Health Guidelines with a Treadmill Desk
8. Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications
9. Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products : Government and Industry Increase Contaminant Testing to Increase Food Safety
10. World Publics See Government as Responsible for Ensuring Basic Healthcare, Food, and Education Needs
11. Extra cash from government program linked to higher risk of adult obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6GeoVax Labs Requests pre IND Meeting With FDA 14181 1GeoVax Labs Requests pre IND Meeting With FDA 14181 2GeoVax Labs Requests pre IND Meeting With FDA 14181 3Dalton Pharma Services Adds Formulation Development Services 57793 1Dalton Pharma Services Adds Formulation Development Services 57793 2Atlantic Partners with Childrens Hospital of Philadelphia to Create an Interactive 26 Educational Waiting Room 57788 1Atlantic Partners with Childrens Hospital of Philadelphia to Create an Interactive 26 Educational Waiting Room 57788 2